Department of Energy Selects BWXT to Support Nonproliferation Fuel Program
(LYNCHBURG, Va. – Feb. 11, 2020) – BWX Technologies, Inc. (NYSE: BWXT) announced today that the U.S. Department of Energy’s National Nuclear Security Administration (NNSA) has awarded an initial $3.6 million contract to the BWXT Nuclear Operations Group, Inc. subsidiary as the manufacturer of a uranium-molybdenum alloy High Assay Low Enriched Uranium (U-Mo HALEU) fuel […]
BWXT Subsidiary Completes Strategic Acquisition of Laker Energy Products Inc.

(CAMBRIDGE, Ontario – January 2, 2020) – BWX Technologies, Inc. announced today that its subsidiary BWXT Canada Ltd. (BWXT Canada) has acquired Laker Energy Products Inc. (Laker Energy Products). The transaction broadens BWXT’s portfolio of critical CANDU® components for its global customer base. Laker Energy Products, a Canadian company founded in 1995, is a leading […]
BWXT Advancing TRISO Line Restart With Solution Production
(LYNCHBURG, Va. – December 18, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its TRISO nuclear fuel manufacturing restart activities are progressing ahead of schedule. BWXT technicians are now producing uranium solutions for TRISO fuel as the company moves forward with its previously announced plans to restart its manufacturing line and increase capacity at its […]
BWXT Named Among Top 50 Best Companies for Environmental, Social and Governance Practices
(LYNCHBURG, Va. – December 5, 2019) – BWX Technologies, Inc. (BWXT) has been named to Investor’s Business Daily’s 50 Best Environmental, Social and Governance Companies list. The publication recognized companies with superior environmental, social and governance ratings in addition to strong fundamental and technical performance. Among companies with environmental, social and governance ratings of AAA or […]
BWXT Names Dave Broussard General Manager of Barberton, Ohio Operations
(BARBERTON, Ohio – Dec. 2, 2019) – BWX Technologies, Inc. (NYSE:BWXT) announced today that Dave Broussard has been named general manager of the BWXT Nuclear Operations Group, Inc. (BWXT NOG) manufacturing facility in Barberton, Ohio. “With 30 years of experience leading and innovating in high-consequence operations, Dave is well-qualified to lead our Barberton manufacturing operations,” […]
BWX Technologies Reports Record Third Quarter 2019 Results; Increases Full-Year 2019 Non-GAAP EPS Guidance
BWX Technologies Reports Record Third Quarter 2019 Results; Increases Full-Year 2019 Non-GAAP EPS Guidance November 04, 2019 04:30 PM Eastern Standard Time LYNCHBURG, Va.-(BUSINESS WIRE)-BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported third quarter 2019 revenue of $506 million, a new quarterly record for the Company and an 18.9% increase compared […]
BWXT to Produce Medical Radioisotope Germanium-68 to Address Rise in Demand
(LYNCHBURG, Va. – October 30, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it plans to produce the medical radioisotope Germanium-68 (Ge-68) with a focus on addressing a growing global demand for the product. BWXT’s isotope technologies group in Canada has developed proprietary manufacturing technology to produce high purity Ge-68 and is in […]
BWXT to Restart Existing TRISO Nuclear Fuel Production Line and Expand Capacity
Company to hireup to 60 new workers to attain increased production targets (LYNCHBURG, Va. – Oct. 2, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it is in the process of restarting its existing TRISO nuclear fuel production line and is planning to expand its existing capacity within approximately 12 months. The expansion […]
BWXT Announces Availability of FDA-Approved Indium In-111 Oxyquinoline Solution
(LYNCHBURG, Va. – September 26, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT ITG Canada, Inc., having received approval from the U.S. Food and Drug Administration (FDA) on its abbreviated new drug application for its generic version of Indium In-111 Oxyquinoline Solution, is now making the product available for sale in […]
BWX Technologies Reports Second Quarter 2019 Results With Solid Revenue and EPS Growth
Lynchburg, VA – August 5, 2019 – BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported second quarter 2019 revenue of $471 million, a 7.4% increase compared with $439 million in the second quarter of 2018. GAAP net income for the second quarter 2019 was $58.9 million, or $0.62 per diluted share, compared […]